la jolla
-
Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation
Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Aira takes its Google Glass navigation for visually impaired to non-U.S. markets
In addition to airports, the company’s Google Glass-enabled technology has been used to help individuals navigate college campuses, train stations, and city centers.
-
An employer benefits adviser has launched a genomic testing advisory business
The goal of the La Jolla, California-based company, is to make genomic testing readily accessible and affordable for everyone through employer plans.
-
Venter steps down as CEO of Human Longevity
J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.
-
West Health CEO retiring; here’s what he’s accomplished
Nick Valeriani will retire as CEO of West Health in September, and be replaced by current COO Shelley Lyford, who also is president and CEO the Gary and Mary West Foundation, the entity that sponsors West Health.